Effect of Targeted blockage of the rhoKinases pathway on maturation of dendritic cells in culture: alternative treatment for transplant rejections (BLACKCELLS) (Q3696565): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): In a translational study, the authors propose to verify the immunomodulatory effect of a new molecule: a Rhokinase inhibitor (Y-39983) on dendritic cells in culture, the main cells involved in transplant rejection., translated_summary) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Effect of Targeted blockage of the rhoKinases pathway on maturation of dendritic cells in culture: alternative treatment for transplant rejections (BLACKCELLS) | |||
Revision as of 10:40, 22 November 2021
Project Q3696565 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of Targeted blockage of the rhoKinases pathway on maturation of dendritic cells in culture: alternative treatment for transplant rejections (BLACKCELLS) |
Project Q3696565 in France |
Statements
0.0 Euro
0 references
0.0 Euro
0 references
50.0 percent
0 references
1 July 2015
0 references
31 December 2017
0 references
Centre Hospitalier Régional METZ-THIONVILLE
0 references
Dans le cadre d’une étude translationnelle, les auteurs proposent de vérifier l’effet immunomodulateur d’une molécule nouvelle : un inhibiteur de Rhokinase (Y-39983) sur les cellules dendritiques en culture, principales cellules impliquées dans le rejet de greffe. (French)
0 references
In a translational study, the authors propose to verify the immunomodulatory effect of a new molecule: a Rhokinase inhibitor (Y-39983) on dendritic cells in culture, the main cells involved in transplant rejection. (English)
22 November 2021
0 references
Identifiers
LO0007464
0 references